MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202647092522 A) filed by Oncoc, Inc. on July 30, 2026, for Anti-Cd24 Antibody Drug Conjugates And Uses Thereof.
Inventors include Liu, Yang; Weiss, Ido D.; Poudel, Nabin; and Tong, Dan.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Provided herein are antibody-drug conjugates containing an anti-CD24 antibody conjugated to a cytotoxic agent via a linker, in which the antibody selectively binds to human CD24 protein expressed on cancer cells but not human CD24 expressed in non-cancerous cells; and uses thereof for treating cancer.
Disclaimer: Curated by HT Syndication.
